Рет қаралды 9,257
Patient and physician considerations for switching between Rituxan IV and Rituxan Hycela, the subcutaneous formulation, during non-Hodgkin lymphoma treatment.
View more at curetoday.com/
CURE: Combining science and humanity to make cancer understandable.